CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Medicine, Inc. (NASDAQ:FMI) today announced that members of the
company's management team will present at the following upcoming
Michael J. Pellini, M.D., chief executive officer, will present at the
Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday,
May 12, 2015, at 2:20 p.m. P.T. in Las Vegas.
Jason Ryan, chief financial officer, will present at the UBS Global
Healthcare Conference on Monday, May 18, 2015, at 3:30 p.m. E.T. in
New York City.
Live, listen-only webcasts of the presentations may be accessed by
visiting the investors section of the company's website at investors.foundationmedicine.com.
Replays of the webcasts will be available shortly after the conclusion
of the presentations and will be archived on the company's website for
About Foundation Medicine
Foundation Medicine (NASDAQ: FMI) is a molecular information company
dedicated to a transformation in cancer care in which treatment is
informed by a deep understanding of the genomic changes that contribute
to each patient's unique cancer. The company's clinical assays,
FoundationOne® for solid tumors and FoundationOne® Heme for hematologic
malignancies and sarcomas, provide a fully informative genomic profile
to identify the molecular alterations in a patient's cancer and match
them with relevant targeted therapies and clinical trials. Foundation
Medicine's molecular information platform aims to improve day-to-day
care for patients by serving the needs of clinicians, academic
researchers and drug developers to help advance the science of molecular
medicine in cancer. For more information, please visit http://www.FoundationMedicine.com
or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® and FoundationOne®
are registered trademarks of Foundation Medicine, Inc.
Dan Budwick, Pure Communications, Inc.
Susan Hager, 617-418-2258
Source: Foundation Medicine, Inc.
News Provided by Acquire Media